Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Microbiome Modulation Therapy (MBMT) + Chemotherapy in Metastatic Colorectal Cancer
NCT06728072Phase 2Recruiting
- Sponsor
- Virginia Commonwealth University
- Start
- Mar 2025
- Primary completion
- Jul 2035
- Countries
- 1
01
Overview
A Phase 2 trial of ciprofloxacin, metronidazole, aspirin in colorectal cancer (CRC), sponsored by Virginia Commonwealth University. Started Mar 2025; status: recruiting.
02
Drugs
ciprofloxacinmetronidazoleaspirin
03
Conditions
colorectal cancer (CRC)
Beyond the preview
Go deeper on NCT06728072.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT06728072.